Genetic testing benefits for people diagnosed with , ovarian or primary peritoneal cancer
For women who have been diagnosed with , ovarian or primary peritoneal cancer, genetic testing may provide the following information and benefit:
- Your test results may make you eligible for treatment with a (e.g., PARP inhibitors) or a clinical trial.
- If you test positive for an inherited mutation in , , , or , you may benefit from treatment with an agent.
- The test can help you understand your risk for a new cancer diagnosis and options for managing your risk.
- Your results can help your relatives understand their risk for cancer and take actions to stay healthy.
Last updated February 02, 2022